Cerulean licenses drug delivery technology for nano drugs
This article was originally published in Scrip
Executive Summary
Cerulean Pharma has acquired an exclusive worldwide licence to Calando Pharmaceuticals' cyclodextrin co-polymer based drug delivery technology to develop and commercialise therapeutic products arising from the application of this technology.